Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 37 Prostatic Neoplasms 12 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Liver Neoplasms 3 Fibrosis 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Intraductal, Noninfiltrating 3 Uterine Cervical Neoplasms 2 Thyroid Nodule 2 Stomach Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lymphoma 2 Lymphedema 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Inflammatory Breast Neoplasms 2 Infertility 2 Hodgkin Disease 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Medullary 2 Carcinoma, Hepatocellular 2 Anatomic Stage III Breast Cancer AJCC v8 2

Interventions

Sorafenib 5 Blood Specimen Collection 4 lenvatinib 3 sintilimab 2 pembrolizumab 2 ledipasvir, sofosbuvir drug combination 2 halofantrine 2 camrelizumab 2 atezolizumab 2 Liver Transplantation 2 Immunotherapy 2 Control Groups 2 Bevacizumab 2 Antibodies 2 veliparib 1 trifluridine tipiracil drug combination 1 trametinib 1 toripalimab 1 titanium silicide 1 tislelizumab 1 rubitecan 1 repotrectinib 1 pevonedistat 1 ozanimod 1 linifanib 1 genexol-PM 1 gadolinium ethoxybenzyl DTPA 1 fluorocholine 1 fisogatinib 1 ficlatuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × High-Energy Shock Waves × Clear all

NCT03811431 2019-01-22

ConCLUDe

Iuliu Hatieganu University of Medicine and Pharmacy

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡